✦ LIBER ✦

Heart failure drug discovery: Scarred or ready for remodeling?

✍ Scribed by Andrew Plump; Jeffrey Madwed

Book ID: 117984284
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 174 KB
Volume: 51
Category: Article
ISSN: 0022-2828
DOI: 10.1016/j.yjmcc.2011.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drugs for Left Ventricular Remodeling in

Drugs for Left Ventricular Remodeling in Heart Failure

✍ Maria Frigerio; Elena Roubina 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Natriuretic Peptide-Guided Therapy for H

Natriuretic Peptide-Guided Therapy for Heart Failure: Ready for “Battle” or Too “Scarred” by the Challenges of Trial Design?

✍ Alan Maisel 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Drug discovery for heart failure: a new

Drug discovery for heart failure: a new era or the end of the pipeline?

✍ Kaye, David M.; Krum, Henry 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 409 KB

Drug discovery and development for acute

Drug discovery and development for acute heart failure drugs: Are expectations too high?

✍ Pollesello, Piero 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 291 KB

[Methods and Principles in Medicinal Che

[Methods and Principles in Medicinal Chemistry] In Vivo Models for Drug Discovery || Heart Failure

✍ Vela, José M.; Maldonado, Rafael; Hamon, Michel 📂 Article 📅 2014 🏛 Wiley 🌐 German ⚖ 263 KB

This One-stop Reference Is The First To Present The Complete Picture -- Covering All Relevant Organisms, From Single Cells To Mammals, As Well As All Major Disease Areas, Including Neurological Disorders, Cancer And Infectious Diseases. Addressing The Needs Of The Pharmaceutical Industry, This Uniqu

Angiotensin II receptor antagonists, eli

Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?

✍ Beevers, D G; Lip, G Y H 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB